Volitionrx Limited (VNRX) Misses Q1 EPS by 2c

Volitionrx Limited (NYSE: VNRX) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $250 thousand versus the consensus estimate of $1.31 million.

For earnings history and earnings-related data on Volitionrx Limited (VNRX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Rothschild Redburn Upgrades Apple (AAPL) to Buy
• DOMO (DOMO) Reiterated at Market Underperform by Citizens Amid PRGS Transaction